Warsaw-based direct-to-consumer personalised supplement platform Sundose has raised $6 million in a Series A round led by DX Ventures and Atmos Ventures. The round saw follow on from Investible Club, Polipo Ventures, and Aria.
The funding is expected to further develop the company’s personalisation engine, scale production, and expand operations to more European markets.
Founded in 2017 by Michał Gołkiewicz and Tomasz Styk, Sundose uses a proprietary supplement formulation method that seeks to replace the current status quo of “one-size-fits-all” vitamins and minerals. This dynamic method allows for the individual tailoring of supplements, one that can be regularly adjusted according to the consumer’s lifestyle, age, and medical history.
“The finished product is a daily sachet with a unique nutrient mix from our selection of over 40 vitamins, minerals, essential fatty acids, probiotics, and adaptogens,” comments Gołkiewicz. “We can, quite literally, offer billions of unique end products to our customers.”
With a global annual spend of approximately $140 billion, the supplement industry is no laughing matter. The global pandemic triggered an explosion in the sector, and according to Grand Markets Research, that number is predicted to jump to $230.7 billion.
“Sundose is revolutionising the way European consumers purchase and consume dietary supplements, with all of the potential health benefits that come with that,” says DX Ventures Partner Brendon Blacker. “The Sundose team has a clear vision to transform the experience of taking supplements and a track record of innovation to be able to deliver on that vision.”